Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Shear

Showing results (161-170 of 188) with videos related to

Pageof 19
Sort By:
Dermatology (Basel, Switzerland)|September 13, 2008
A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasisT A Luger, F Cambazard, F G Larsen, et al.
The British Journal of Dermatology|June 24, 2006
CLinical experience acquired with the efalizumab (Raptiva) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trialL Dubertret, W Sterry, J D Bos, et al.
The British Journal of Dermatology|March 29, 2014
Long-term efficacy and safety of infliximab maintenance therapy in patients with plaque-type psoriasis in real-world practiceN H Shear, M Hartmann, M Toledo-Bahena, et al.
Journal of the American Geriatrics Society|August 12, 1999
Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective doseP A Rochon, G M Anderson, J V Tu, et al.
The British Journal of Dermatology|September 15, 2007
Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndromeM Tohyama, K Hashimoto, M Yasukawa, et al.
The British Journal of Dermatology|March 17, 2021
Blistering severe cutaneous adverse reactions in children: proposal for paediatric-focused clinical criteriaM L Ramien, A Bahubeshi, I Lara-Corrales, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 26, 2018
Tinea capitis in children: a systematic review of managementA K Gupta, R R Mays, S G Versteeg, et al.
The British Journal of Dermatology|March 20, 2014
Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded studyA J Kanwar, K Vinay, G U Sawatkar, et al.
Lancet (London, England)|April 22, 2008
Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III studyK Papp, R Bissonnette, L Rosoph, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in childrenU Amstutz, C J D Ross, L I Castro-Pastrana, et al.
Pageof 19

Showing results (161-170 of 188) with videos related to

Sort By:
Pageof 19
Dermatology (Basel, Switzerland)|September 13, 2008
A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasisT A Luger, F Cambazard, F G Larsen, et al.
The British Journal of Dermatology|June 24, 2006
CLinical experience acquired with the efalizumab (Raptiva) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trialL Dubertret, W Sterry, J D Bos, et al.
The British Journal of Dermatology|March 29, 2014
Long-term efficacy and safety of infliximab maintenance therapy in patients with plaque-type psoriasis in real-world practiceN H Shear, M Hartmann, M Toledo-Bahena, et al.
Journal of the American Geriatrics Society|August 12, 1999
Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective doseP A Rochon, G M Anderson, J V Tu, et al.
The British Journal of Dermatology|September 15, 2007
Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndromeM Tohyama, K Hashimoto, M Yasukawa, et al.
The British Journal of Dermatology|March 17, 2021
Blistering severe cutaneous adverse reactions in children: proposal for paediatric-focused clinical criteriaM L Ramien, A Bahubeshi, I Lara-Corrales, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 26, 2018
Tinea capitis in children: a systematic review of managementA K Gupta, R R Mays, S G Versteeg, et al.
The British Journal of Dermatology|March 20, 2014
Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded studyA J Kanwar, K Vinay, G U Sawatkar, et al.
Lancet (London, England)|April 22, 2008
Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III studyK Papp, R Bissonnette, L Rosoph, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in childrenU Amstutz, C J D Ross, L I Castro-Pastrana, et al.
Pageof 19